Recombinant human thrombopoietin - BiolotusAlternative Names: rhTPO - Biolotus; TPO - Biolotus; ZYPOTIN-TPO
Latest Information Update: 18 Jun 2015
At a glance
- Originator Biolotus
- Class Colony-stimulating factors; Glycoproteins
- Mechanism of Action Thrombopoietin stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Thrombocytopenia
Most Recent Events
- 18 Jun 2015 Launched for Thrombocytopenia in Brazil (SC) before June 2015